Our results demonstrate that mammary gland targeted cortactin did not affect mammary epithelial cell morphology and did not provide proliferative advantages in the development of (pre-malignant) breast tumor in either WT or MMTV-cyclin D1 transgenic mice. The gene discussed is CCND1; the disease is breast neoplasm.